EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 2 May 2023. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): NAV per share (including Revaluation Surplus) was Tk. 87.37 as on March 31, 2023 and Tk. 82.53 as on June 31, 2022. Reason for deviation in EPS and NOCFPS: EPS has been decreased due to increases of goods sold and cost of power generation. (cont.2)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 64508965a7ae9d7645dd8d4a
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.